pancreatic cancer

2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin
FDA halts Halozyme's pancreatic cancer study
Yahoo/Reuters
Wed, 04/9/14 - 08:49 am
pancreatic cancer
FDA
Halozyme
Pancreatic Cancer Trial Enrollment Halt Damages Halozyme
Yahoo/247WallStreet
Fri, 04/4/14 - 09:31 am
Halozyme
pancreatic cancer
PEGPH20
Celgene reiterates commitment to improving pancreatic cancer care in Europe
Yahoo/Fly on the Wall
Wed, 03/19/14 - 09:52 am
Celgene
pancreatic cancer
Europe
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule
TheStreet.com
Wed, 02/26/14 - 09:04 am
pancreatic cancer
vaccine
HyperAcute Pancreas
NewLink Genetics
Celgene's Abraxane Under Fire in NEJM Letter
TheStreet.com
Thu, 01/30/14 - 10:10 am
New England Journal of Medicine
Abraxane
Celgene
pancreatic cancer
breast cancer
lung cancer
Positive Oncology News Lifts OncoMed
Yahoo/Zacks.com
Mon, 01/20/14 - 07:00 pm
OncoMed
OMP-59R5
demcizumab
pancreatic cancer
Onconova tanks as its lead candidate flunks PhIII for pancreatic cancer
Fierce Biotech
Wed, 12/18/13 - 12:09 pm
Rigosertib
pancreatic cancer
Onconova
Abraxane's Approval for Pancreatic Cancer Is a Major Milestone for Celgene
Motley Fool
Mon, 09/30/13 - 11:40 am
Celgene
pancreatic cancer
Abraxane
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:35 pm
TSR-011
pancreatic cancer
Tesaro
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Sat, 09/14/13 - 11:00 am
Celgene Corporation
Abraxane
pancreatic cancer
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Fri, 09/13/13 - 08:27 am
Celgene
pancreatic cancer
Abraxane
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
NY Times
Sat, 09/7/13 - 11:45 am
Abraxane
Celgene
pancreatic cancer
Merrimack Progresses With MM-398
Yahoo/Zacks
Fri, 08/30/13 - 08:45 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Sat, 08/24/13 - 11:42 am
Incyte
Jakafi
pancreatic cancer
Merrimack Study Data Published
Yahoo/Zacks
Sat, 08/24/13 - 11:36 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Incyte
JAK inhibitors
Jakafi
pancreatic cancer
Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Incyte
pancreatic cancer
Jakafi
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Mon, 06/10/13 - 10:56 am
Celgene
Abraxane
pancreatic cancer
Novartis
Pfizer
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer

Pages